These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 16441600)
1. Controlled-rate versus uncontrolled-rate freezing as predictors for platelet cryopreservation efficacy. Balint B; Paunovic D; Vucetic D; Vojvodic D; Petakov M; Trkuljic M; Stojanovic N Transfusion; 2006 Feb; 46(2):230-5. PubMed ID: 16441600 [TBL] [Abstract][Full Text] [Related]
2. Quantitative, functional, morphological and ultrastructural recovery of platelets as predictor for cryopreservation. Balint B; Vucetić D; Trajković-Lakić Z; Petakov M; Bugarski D; Brajusković G; Taseski J Haematologia (Budap); 2002; 32(4):363-75. PubMed ID: 12803111 [TBL] [Abstract][Full Text] [Related]
3. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80 degrees C without postthaw processing. Valeri CR; Ragno G; Khuri S Transfusion; 2005 Dec; 45(12):1890-8. PubMed ID: 16371041 [TBL] [Abstract][Full Text] [Related]
4. Microprocessor-controlled vs. "dump-freezing"platelet and lymphocyte cryopreservation: a quantitative and qualitative comparative study. Balint B; Vucetić D; Drasković B; Vojvodić D; Brajusković G; Colić M; Trkuljić M Vojnosanit Pregl; 2006 Mar; 63(3):261-8; discussion 269-70. PubMed ID: 16605192 [TBL] [Abstract][Full Text] [Related]
6. Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study. Group for Cryobiology and Biology of Bone Marrow Transplantation (CBTMO), Spain. Perez-Oteyza J; Bornstein R; Corral M; Hermosa V; Alegre A; Torrabadella M; Ramos P; Garcia J; Odriozola J; Navarro JL Haematologica; 1998 Nov; 83(11):1001-5. PubMed ID: 9864921 [TBL] [Abstract][Full Text] [Related]
7. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution. Johnson LN; Winter KM; Reid S; Hartkopf-Theis T; Marks DC Cryobiology; 2011 Apr; 62(2):100-6. PubMed ID: 21241687 [TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of buffy coat derived platelets: Paired in vitro characterization using uncontrolled versus controlled freezing rate protocols. Tynngård N; Bell A; Gryfelt G; Cvetkovic S; Wikman A; Uhlin M; Sandgren P Transfusion; 2021 Feb; 61(2):546-556. PubMed ID: 33345368 [TBL] [Abstract][Full Text] [Related]
9. Effects of pretransfusion warming of platelets to 35 degrees C on posttransfusion platelet viability. Slichter SJ; Christoffel T; Corson J; Jones MK; Pellham E; Bolgiano D Transfusion; 2009 Nov; 49(11):2319-25. PubMed ID: 19624609 [TBL] [Abstract][Full Text] [Related]
10. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Skripchenko A; Kurtz J; Moroff G; Wagner SJ Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181 [TBL] [Abstract][Full Text] [Related]
11. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Sandgren P; Callaert M; Shanwell A; Gulliksson H Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379 [TBL] [Abstract][Full Text] [Related]
12. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension. Valeri CR; Macgregor H; Ragno G Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682 [TBL] [Abstract][Full Text] [Related]